[1]
PARMAR VINENDRA M and GOSWAMI SUNITA S, “EFFICACY AND SAFETY OF TENELIGLIPTIN AS ADD-ON THERAPY TO CONVENTIONAL THERAPY IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Asian J Pharm Clin Res, vol. 12, no. 12, pp. 116–120, Dec. 2019.